Web28 Jul 2009 · Generating and Engineering Novel Antibody Binding Sites. G. Georgiou (University of Texas at Austin, USA) presented exciting work on the production in E.coli of … Web1 Mar 2011 · To relate nanoparticles with the more classical antibody therapeutics, Thierry Wurch (Institut de Recherche Pierre Fabre, Centre d'Immunologie Pierre Fabre) presented novel data on the influence of the antibody hinge region and the control of its intrinsic activity. The particular hinge region provides structural flexibility to both variable and …
observatorio.ubiobio.cl
WebBibTeX @MISC{Arnett_ibc’s21, author = {Samantha O. Arnett and Jean-luc Teillaud and Thierry Wurch and Janice M. Reichert and Cameron Dunlop and Michael Huber}, title = {IBC’s 21 st Annual Antibody Engineering and 8 th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of The Antibody Society}, year = {}} Web1 Nov 2004 · Peroxisome proliferator-activated receptors (PPARs) regulate storage and catabolism of fats and carbohydrates. PPARγ activity increases insulin sensitivity and adipocyte differentiation at the expense of adipogenesis and weight gain. The goal of this study was to 1) clone the promoter of the human adipocyte fatty acid binding protein … china healthcare security
Our Global External Innovation & Partnering Team - Ipsen
WebBeck Alain, Wagner-Rousset Elsa, Bussat Marie-Claire, Lokteff Maryline, Klinguer-Hamour Christine, Haeuw Jean-François, Goetsch Liliane, Wurch Thierry, Dorsselaer Van Alain and Corvaia Nathalie, Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins, Current Pharmaceutical Biotechnology … WebIn their Timeline article, Alain Beck, Thierry Wurch, Christian Bailly and Nathalie Corvaia provide an overview of the strategies for therapeutic antibody development. But what are the key ... WebThierry Wurch, Just - Evotec Biologics' SVP Integrated Biologics Discovery, will be chairing Discngine Labs’ upcoming webinar on “Predicting Antibody Developability in silico & in vitro ... china healthcare statistics